Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients

Antigen-presenting cells are crucial for the induction of an antigen-specific antitumoral immune response. Deteriorations in the expression pattern of cell surface molecules important for the presentation of antigens might therefore be indicative of an impaired immune response status in cancer patie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ugurel, Selma (VerfasserIn) , Schadendorf, Dirk (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 16 January 2004
In: Cancer immunology immunotherapy
Year: 2004, Jahrgang: 53, Heft: 6, Pages: 551-559
ISSN:1432-0851
DOI:10.1007/s00262-003-0489-1
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00262-003-0489-1
Volltext
Verfasserangaben:Selma Ugurel, Dario Uhlig, Claudia Pföhler, Wolfgang Tilgen, Dirk Schadendorf, Uwe Reinhold

MARC

LEADER 00000caa a2200000 c 4500
001 1741031788
003 DE-627
005 20230428021703.0
007 cr uuu---uuuuu
008 201125s2004 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00262-003-0489-1  |2 doi 
035 |a (DE-627)1741031788 
035 |a (DE-599)KXP1741031788 
035 |a (OCoLC)1341377837 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ugurel, Selma  |d 1971-  |e VerfasserIn  |0 (DE-588)122030923  |0 (DE-627)081693532  |0 (DE-576)293057567  |4 aut 
245 1 0 |a Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients  |c Selma Ugurel, Dario Uhlig, Claudia Pföhler, Wolfgang Tilgen, Dirk Schadendorf, Uwe Reinhold 
246 3 0 |a two 
264 1 |c 16 January 2004 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.11.2020 
520 |a Antigen-presenting cells are crucial for the induction of an antigen-specific antitumoral immune response. Deteriorations in the expression pattern of cell surface molecules important for the presentation of antigens might therefore be indicative of an impaired immune response status in cancer patients. In the present study we investigated the expression of MHC class I and class II molecules, of the costimulatory molecules CD80/B7-1 and CD86/B7-2, of the adhesion molecule CD11c, and of the marker of activation CD71 on CD14+ peripheral blood monocytes (PBMs) from 144 melanoma patients in different stages of disease and 43 healthy controls, by flow cytometric analysis. We found a decreased expression of HLA-DR (p<0.0005), HLA-DQ (p=0.006), HLA-DP (p<0.0005), and CD86/B7-2 (p=0.001) on PBMs from melanoma patients compared with healthy controls, whereas no significant difference could be detected in the expression of HLA class I antigens and CD80/B7-1. This down-regulated expression was associated with disease progression. In contrast, CD71 expression was stage-dependently increased on PBMs from melanoma patients compared with healthy controls (p=0.024). No correlation was found between the PBM surface expression pattern and age, gender, tumor load, and current mode of therapy of the patients. The observed down-regulation of HLA class II and CD86/B7-2 on melanoma patients’ PBMs might reflect an ineffective antigen-presenting function contributing to an impaired antigen-specific immune response in these patients. 
700 1 |a Schadendorf, Dirk  |d 1960-  |e VerfasserIn  |0 (DE-588)11142576X  |0 (DE-627)499566076  |0 (DE-576)289702275  |4 aut 
773 0 8 |i Enthalten in  |t Cancer immunology immunotherapy  |d Berlin : Springer, 1976  |g 53(2004), 6, Seite 551-559  |h Online-Ressource  |w (DE-627)253390443  |w (DE-600)1458489-X  |w (DE-576)072283475  |x 1432-0851  |7 nnas  |a Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients 
773 1 8 |g volume:53  |g year:2004  |g number:6  |g pages:551-559  |g extent:9  |a Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients 
856 4 0 |u https://doi.org/10.1007/s00262-003-0489-1  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201125 
993 |a Article 
994 |a 2004 
998 |g 11142576X  |a Schadendorf, Dirk  |m 11142576X:Schadendorf, Dirk  |d 50000  |e 50000PS11142576X  |k 0/50000/  |p 5 
998 |g 122030923  |a Ugurel, Selma  |m 122030923:Ugurel, Selma  |p 1  |x j 
999 |a KXP-PPN1741031788  |e 3812228424 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Selma Ugurel, Dario Uhlig, Claudia Pföhler, Wolfgang Tilgen, Dirk Schadendorf, Uwe Reinhold"]},"person":[{"roleDisplay":"VerfasserIn","family":"Ugurel","given":"Selma","display":"Ugurel, Selma","role":"aut"},{"family":"Schadendorf","roleDisplay":"VerfasserIn","role":"aut","display":"Schadendorf, Dirk","given":"Dirk"}],"physDesc":[{"extent":"9 S."}],"relHost":[{"pubHistory":["1.1976 -"],"titleAlt":[{"title":"CII"}],"recId":"253390443","note":["Gesehen am 15.05.2024","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 52.2003: Supplement"],"disp":"Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patientsCancer immunology immunotherapy","title":[{"title":"Cancer immunology immunotherapy","title_sort":"Cancer immunology immunotherapy","subtitle":"CII"}],"id":{"zdb":["1458489-X"],"eki":["253390443"],"issn":["1432-0851"]},"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"53","issue":"6","text":"53(2004), 6, Seite 551-559","pages":"551-559","extent":"9","year":"2004"},"origin":[{"publisher":"Springer","dateIssuedKey":"1976","publisherPlace":"Berlin ; Heidelberg","dateIssuedDisp":"1976-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"]}],"origin":[{"dateIssuedKey":"2004","dateIssuedDisp":"16 January 2004"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1741031788","id":{"eki":["1741031788"],"doi":["10.1007/s00262-003-0489-1"]},"title":[{"title":"Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients","title_sort":"Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients"}],"note":["Gesehen am 25.11.2020"]} 
SRT |a UGURELSELMDOWNREGULA1620